Home
MGX
MGX News

Latest METAGENOMI INC (MGX) News on April 4, 2025

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks

3 days ago

Biotech stocks slide as Marks resignation seen being negative for sector

Bullish: Analysts Just Made A Significant Upgrade To Their Metagenomi, Inc. (NASDAQ:MGX) Forecasts

Simply Wall St.

8 days ago

Bullish: Analysts Just Made A Significant Upgrade To Their Metagenomi, Inc. (NASDAQ:MGX) Forecasts

MT Newswires

17 days ago

Chardan Adjusts Price Target on Metagenomi to $13 From $15, Keeps Buy Rating

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

GlobeNewswire

18 days ago

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

GlobeNewswire

22 days ago

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

Alto Ingredients And 2 Other US Penny Stocks To Watch

Simply Wall St.

2 months ago

Alto Ingredients And 2 Other US Penny Stocks To Watch

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

GlobeNewswire

2 months ago

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

GlobeNewswire

2 months ago

Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

People are buying the wrong stock thinking it's part of OpenAI's Stargate Project

Quartz

2 months ago

People are buying the wrong stock thinking it's part of OpenAI's Stargate Project

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

GlobeNewswire

3 months ago

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

Metagenomi Announces New Appointment to its Board of Directors

GlobeNewswire

3 months ago

Metagenomi Announces New Appointment to its Board of Directors

Metagenomi, Inc.'s (NASDAQ:MGX) market cap dropped US$12m last week; individual investors who hold 33% were hit as were institutions

Simply Wall St.

3 months ago

Metagenomi, Inc.'s (NASDAQ:MGX) market cap dropped US$12m last week; individual investors who hold 33% were hit as were institutions

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

3 months ago

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

GlobeNewswire

4 months ago

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

GlobeNewswire

4 months ago

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks

TipRanks

4 months ago

Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks

What Makes Metagenomi (MGX) a New Buy Stock

Zacks

5 months ago

What Makes Metagenomi (MGX) a New Buy Stock

Metagenomi Third Quarter 2024 Earnings: US$0.51 loss per share (vs US$3.33 loss in 3Q 2023)

Simply Wall St.

5 months ago

Metagenomi Third Quarter 2024 Earnings: US$0.51 loss per share (vs US$3.33 loss in 3Q 2023)

Associated Press Finance

5 months ago

Metagenomi: Q3 Earnings Snapshot

Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

GlobeNewswire

5 months ago

Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting

GlobeNewswire

5 months ago

Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting

Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT

GlobeNewswire

5 months ago

Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT

Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies

GlobeNewswire

6 months ago

Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies

Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference

GlobeNewswire

7 months ago

Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference

We Think Metagenomi (NASDAQ:MGX) Needs To Drive Business Growth Carefully

Simply Wall St.

7 months ago

We Think Metagenomi (NASDAQ:MGX) Needs To Drive Business Growth Carefully

Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months

GlobeNewswire

7 months ago

Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months

Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference

GlobeNewswire

7 months ago

Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference

Metagenomi to Participate in Upcoming Investor Conferences

GlobeNewswire

7 months ago

Metagenomi to Participate in Upcoming Investor Conferences

MT Newswires

8 months ago

Chardan Adjusts Price Target on Metagenomi to $15 From $17, Maintains Buy Rating

Associated Press Finance

8 months ago

Metagenomi: Q2 Earnings Snapshot

Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results

GlobeNewswire

8 months ago

Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results

Metagenomi, Inc. (MGX): This New Penny Stock Received a Positive Rating From Street Analysts

Insider Monkey

8 months ago

Metagenomi, Inc. (MGX): This New Penny Stock Received a Positive Rating From Street Analysts

With 33% stake, Metagenomi, Inc. (NASDAQ:MGX) seems to have captured institutional investors' interest

Simply Wall St.

8 months ago

With 33% stake, Metagenomi, Inc. (NASDAQ:MGX) seems to have captured institutional investors' interest

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

10 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

10 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

10 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

10 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

10 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

10 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

10 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

10 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference

GlobeNewswire

10 months ago

Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems

GlobeNewswire

a year ago

Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems

Metagenomi to Present at Upcoming Scientific Meetings

GlobeNewswire

a year ago

Metagenomi to Present at Upcoming Scientific Meetings

Metagenomi Reports Business Updates and Full Year 2023 Financial Results

GlobeNewswire

a year ago

Metagenomi Reports Business Updates and Full Year 2023 Financial Results

Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference

GlobeNewswire

a year ago

Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 02/16/2024

Metagenomi Announces Closing of Initial Public Offering

GlobeNewswire

a year ago

Metagenomi Announces Closing of Initial Public Offering

Metagenomi Announces Pricing of Initial Public Offering

GlobeNewswire

a year ago

Metagenomi Announces Pricing of Initial Public Offering

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use